Data Integrity

iSpeak Blog
The issue of data integrity may appear archaic in a highly connected, digital world. Yet many within the pharmaceutical industry it continues – be it intentional or not – to fall foul of regulators tasked with auditing businesses’ practices. Peter Cusworth at Yokogawa examines an age-old problem,...
Video
Complimentary Learning Level: Intermediate Session Length: 60 minutes Based on the new ISPE GAMP Data Integrity by Design Guide, this webinar will examine the underlying concepts around designing data integrity into your...
Guidance Documents
11 November 2020
News & Press Releases
ISPE announced the release of its latest Guide, ISPE GAMP® RDI Good Practice Guide: Data Integrity by Design. This Guide was written by a group of experts and reviewed by regulators and practitioners in the field, and supports a holistic data...
Guidance Docs
This ISPE GAMP® RDI Good Practice Guide: Data Integrity by Design supports organizations as they embrace and implement a holistic approach by leveraging data governance and knowledge management activities to drive continual improvement in data integrity.
iSpeak Blog
In recent years significant problems with data integrity have been found in the pharmaceutical, biotechnology, and medical device industries worldwide. This ultimately affects patients, as patient safety is intrinsically impacted by the integrity and...
Video
This webinar provides an overview of new and forthcoming ISPE GAMP® Data Integrity guidance and real-world experiences on applying data integrity in the field. The speakers will address the following topics: Overview of...
iSpeak Blog
Followers of FDA warning letters and Form 483s will have noticed that over the last 12 – 18 months, there have been increasing mention of data integrity issues around manufacturing data, often as a result of outdated equipment and practices, such...
InTouch
ISPE launched its complimentary Pharma Best Practices Webinar Series in April. The debut was outstanding, drawing more than 850 registrants and over 500 real-time participants representing 62 countries and six regulatory agencies from around the world.
Features
The Pharma 4.0™ Special Interest Group is focusing on key technologies that will modernize pharmaceutical manufacturing and facilitate digital transformation. These technologies include digital twins, augmented reality, artificial intelligence, big data and analytics, mobiles, cloud, advanced...
Guidance Documents
05 June 2019
News & Press Releases
ISPE announced the release of their latest guide, ISPE GAMP® RDI Good Practice Guide: Data Integrity – Manufacturing Records. This guide features the expectations and requirements for data integrity and quality management in GMP facilities. Industry...